Espicom Business Intelligence Ltd, Nov 2011
These reports provide a detailed analysis of four of the most populous countries in the world and the massive potential of their pharmaceutical markets. The markets of Central Asia contrast well
Espicom Business Intelligence Ltd, Nov 2011
and recombinant proteins.
THESE REPORTS ANALYSE THE ISSUES
The The Outlook for Pharmaceuticals in Central & Eastern Europe is a unique collection of management reports from Espicom Business Intelligence. Each
Espicom Business Intelligence Ltd, Jan 2009, Pages: 324
GUATEMALA
MEXICO
NICARAGUA
PANAMA
This new management report, The Outlook for Emerging Central American Pharmaceutical Markets, has been written by Espicom’s Latin American healthcare analyst Ricardo Vicente
ICON Group International, Jan 2011, Pages: 146
PROVISIONS 37.1 Disclaimers & Safe Harbor 37.2 ICON Group International, Inc. User Agreement Provisions The 2011-2016 Outlook for Pharmaceutical Preparations for Human Use Acting on the Central Nervous
ICON Group International, Feb 2011, Pages: 338
.), and there will still be latent demand for pharmaceutical preparations for human use acting on the central nervous system and the sense organs at the aggregate level. Product and service offerings, and the actual
ICON Group International, Jan 2011, Pages: 144
Industrial Outlook, and the World Bank). Depending on original data sources used, the definition of “pharmaceutical preparations affecting the central nervous system and sense organs” is established
ICON Group International, Feb 2011, Pages: 336
Financial Services, the U.S. Industrial Outlook, and the World Bank). Depending on original data sources used, the definition of “pharmaceutical preparations affecting the central nervous system and sense
ICON Group International, Jan 2011, Pages: 172
Provisions The 2011-2016 Outlook for Pharmaceutical Preparations for Human Use Acting on the Central Nervous System and the Sense Organs in Japan
ICON Group International, Jan 2011, Pages: 170
.1 Disclaimers & Safe Harbor 50.2 ICON Group International, Inc. User Agreement Provisions The 2011-2016 Outlook for Pharmaceutical Preparations Affecting the Central Nervous System and Sense Organs in Japan
ICON Group International, Feb 2011, Pages: 751
Industrial Outlook, and the World Bank). Depending on original data sources used, the definition of “pharmaceutical preparations affecting the central nervous system and sense organs” is established
ICON Group International, Feb 2011, Pages: 752
.), and there will still be latent demand for pharmaceutical preparations for human use acting on the central nervous system and the sense organs at the aggregate level. Product and service offerings, and the actual
ICON Group International, May 2009, Pages: 336
Financial Services, the U.S. Industrial Outlook, and the World Bank). Depending on original data sources used, the definition of “pharmaceutical preparations affecting the central nervous system and sense
ICON Group International, Sep 2008, Pages: 201
for certain issues, are relatively unimportant for estimates of latent demand. THE METHODOLOGY In order to estimate the latent demand for pharmaceutical preparations for human use acting on the central
ICON Group International, May 2008, Pages: 172
Harbor 171 50.2 ICON Group International, Inc. User Agreement Provisions 172 The 2009-2014 Outlook for Pharmaceutical Preparations for Human Use Acting on the Central Nervous System and the Sense Organs
ICON Group International, Feb 2009, Pages: 750
.), and there will still be latent demand for pharmaceutical preparations for human use acting on the central nervous system and the sense organs at the aggregate level. Product and service offerings, and the actual
ICON Group International, May 2009, Pages: 338
& Safe Harbor 337 38.2 ICON Group International, Inc. User Agreement Provisions 338 The 2009-2014 Outlook for Pharmaceutical Preparations for Human Use Acting on the Central Nervous System and the Sense
ICON Group International, May 2006, Pages: 197
smaller than the P.I.E. of levels at lower levels of the same value chain, assuming all levels maintain minimum profitability). The latent demand for pharmaceutical preparations affecting the central
ICON Group International, Sep 2008, Pages: 197
Provisions 197 The 2009-2014 World Outlook for Pharmaceutical Preparations Affecting the Central Nervous System and Sense Organs
ICON Group International, May 2008, Pages: 170
Harbor 169 50.2 ICON Group International, Inc. User Agreement Provisions 170 The 2009-2014 Outlook for Pharmaceutical Preparations Affecting the Central Nervous System and Sense Organs in Japan
ICON Group International, Feb 2009, Pages: 749
Industrial Outlook, and the World Bank). Depending on original data sources used, the definition of “pharmaceutical preparations affecting the central nervous system and sense organs” is established